Sunrest Lifescience Limited (NSE:SUNREST)

India flag India · Delayed Price · Currency is INR
33.90
0.00 (0.00%)
Jun 12, 2026, 12:55 PM IST
Market Cap145.47M -46.6%
Revenue (ttm)708.33M +112.0%
Net Income41.16M +105.3%
EPS9.59 +105.4%
Shares Out 4.29M
PE Ratio3.53
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,000
Open33.00
Previous Close33.90
Day's Range33.00 - 33.90
52-Week Range29.55 - 61.00
Beta0.20
Analystsn/a
Price Targetn/a
Earnings DateMay 29, 2026

About Sunrest Lifescience

Sunrest Lifescience Limited manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India. It markets various drugs, including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic, and cosmetics in various forms, such as tablets, capsules, soft gels, syrup, dry-syrups, injections, cream-ointments, and powders. The company sells its products through a network of dist... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2017
Employees 210
Stock Exchange National Stock Exchange of India
Ticker Symbol SUNREST
Full Company Profile

Financial Performance

In fiscal year 2026, Sunrest Lifescience's revenue was 708.33 million, an increase of 111.99% compared to the previous year's 334.13 million. Earnings were 41.16 million, an increase of 105.27%.

Financial Statements